Raymond James Maintains Outperform on Zimmer Biomet Holdings, Raises Price Target to $160

Raymond James maintains Zimmer Biomet Holdings (NYSE:ZBH) with a Outperform and raises the price target from $150 to $160.

Benzinga · 11/06/2019 12:55

Raymond James maintains Zimmer Biomet Holdings (NYSE:ZBH) with a Outperform and raises the price target from $150 to $160.